Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis.

Mehta, Rajesh R; Edwards, Alison M; Rajpathak, Swapnil; Sharma, Ajay; Snow, Kenneth J; Iglay, Kristy

Mehta, Rajesh R; Edwards, Alison M; Rajpathak, Swapnil; Sharma, Ajay; Snow, Kenneth J; Iglay, Kristy.

Afiliação

Mehta RR; Healthagen Outcomes, New York, NY, USA.
Edwards AM; Healthagen Outcomes, New York, NY, USA.
Rajpathak S; Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA.
Sharma A; Healthagen Outcomes, New York, NY, USA.
Snow KJ; Healthagen Outcomes, New York, NY, USA.
Iglay K; Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA.

J Clin Transl Endocrinol ; 19: 100215, 2020 Mar.

Article em En | MEDLINE | ID: mdl-32095429

Palavras-chave

Adherence; Drug therapy; Health care costs; Health care resource use; Type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: J Clin Transl Endocrinol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google